Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
Conditions
- Advanced Non-small Cell Lung Cancer
Interventions
- DRUG: Placebos
- DRUG: Sulijia
Sponsor
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Collaborators